glp-1 and general anesthesia A very important practice-changing consensus statement from the British Journal of Anaesthesia on perioperative management of patients taking receptor agonists such as semaglutide, tirzepatide, and liraglutide. The key message is How should we approach patients

10.1515/tnsci-2022-0245 Translational Neuroscience 198 ShiH.-J.WuD.-L.ChenR.LiN.ZhuL.-J

ForsythCBShannonKMKordowerJHVoigtRMShaikhMJaglinJAet al

Greene DA, Winegrad AI

Mbemba T, Houbion A, Remacle J

Factors that extend the waiting period Several situations warrant waiting longer than the standard timeline: Postpartum hemorrhage or significant blood loss during delivery Preeclampsia or pregnancy-induced hypertension that has not fully resolved Active postpartum depression or anxiety that is not yet stabilized with treatment Difficulty establishing breastfeeding or low milk supply concerns Ongoing wound complications from C-section or perineal repair History of eating disorders, which GLP-1 appetite suppression could trigger Significant nutritional deficiencies identified in postpartum blood work, particularly iron deficiency anemia The American College of Obstetricians and Gynecologists has not yet issued specific guidelines on postpartum GLP-1 use, which means decisions are being made on a case-by-case basis between patients and their providers

Keep your peptides in a small insulated cooler bag with an ice pack to maintain refrigeration temperature during transit